Share This Author
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease…
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Online convex optimization in the bandit setting: gradient descent without a gradient
- A. Flaxman, A. Kalai, H. B. McMahan
- Computer ScienceACM-SIAM Symposium on Discrete Algorithms
- 2 August 2004
It is possible to use gradient descent without seeing anything more than the value of the functions at a single point, and the guarantees hold even in the most general case: online against an adaptive adversary.
SybilGuard: Defending Against Sybil Attacks via Social Networks
- Haifeng Yu, M. Kaminsky, Phillip B. Gibbons, A. Flaxman
- Computer ScienceIEEE/ACM Transactions on Networking
- 11 August 2006
This paper presents SybilGuard, a novel protocol for limiting the corruptive influences of sybil attacks, based on the ldquosocial networkrdquo among user identities, where an edge between two identities indicates a human-established trust relationship.
Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence
The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to secondary and tertiary prevention to reduce the burden of chronic liver disease and to improve survival for those who already have evidence of liver disease.
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
It is calculated that HCV genotype 1 is the most prevalent worldwide, comprising 83.4 million cases (46.2% of all HCV cases), approximately one‐third of which are in East Asia.